Optic Neuropathy

18 registered clinical trials studyying Optic Neuropathy — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies NCT06662448	NYU Langone Health	N/A
Not Yet Recruiting	Clinical Study of FB1001 in Patients NCT06506305	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 1
Completed	Building Research With Artificial Intelligence in Neuro-Ophthalmology NCT06390579	Fondation Ophtalmologique Adolphe de Rothschild	—
Not Yet Recruiting	STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient NCT05747781	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts	N/A
Recruiting	Hyperbaric Oxygen Therapy for Optic Neuropathies NCT06128720	Stanford University	N/A
Unknown	Effect of Intraocular Tamponade on Visual Perception NCT05543018	Benha University	N/A
Completed	Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus NCT05853003	Amira M elSonbaty	—
Completed	Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy NCT04469777	Alexandria University	Phase 1 / Phase 2
Unknown	Assessment of Visual Function With a Portable Brain-computer Interface NCT03760055	NGoggle	—
Terminated	Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis NCT03536559	Clene Nanomedicine	Phase 2
Completed	BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases NCT03318549	University of Miami	N/A
Completed	BIOtinidase Test In Optic-Neuropathy NCT03268681	Fondation Ophtalmologique Adolphe de Rothschild	—
Terminated	Biomechanics of Optic Neuropathy NCT02982499	University of Miami	—
Recruiting	Stem Cell Ophthalmology Treatment Study II NCT03011541	MD Stem Cells	N/A
Completed	Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players NCT02612571	Wills Eye	—
Unknown	Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells NCT02638714	Stem Cells Arabia	Phase 1 / Phase 2
Withdrawn	Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab NCT01331616	West Penn Allegheny Health System	EARLY_Phase 1
Completed	Use of Bevacizumab in Trabeculectomy Surgery NCT01166594	Sunnybrook Health Sciences Centre	Phase 4